MedAssurant and Jefferson School of Population Health Establish Strategic Partnership

PHILADELPHIA, Pennsylvania and BOWIE, Maryland - September 9, 2009 - MedAssurant, Inc., a leading provider of data-driven healthcare solutions, and the Jefferson School of Population Health, a leader in research and education in pharmacoeconomics and population health research, announced today that the two organizations have signed an agreement that will facilitate their collaboration on health economics, comparative effectiveness research, and related healthcare research initiatives.

The Jefferson School of Population Health is an acknowledged leader in pharmacoeconomics and health outcomes research with a mission to prepare leaders with global vision to develop, implement, and evaluate health policies and systems that improve the health of populations and thereby enhance the quality of life. "The opportunity to bring our research and methodologic expertise to MedAssurant's extensive datasets, infrastructural scale, and nationwide interventional capabilities promises to power the next generation of Comparative Effectiveness Research at a time when companies and policy makers desperately need this insight," said David B. Nash, MD, MBA, Dean of the School of Population Health. "Perhaps more exciting still, however, is the ability to apply the results of our combined work to inform solutions designed to achieve meaningful impact in care and outcomes. This is, after all, the goal sought through our work in population health."

Stakeholders across the healthcare landscape are seeking to improve their understanding of the clinical, quality, and economic impacts of specific medications, devices, diagnostics, and differing approaches to care. MedAssurant believes that advanced analytics, applied across large, clinically enriched datasets, are the key to providing the insights that will materially improve the clinical quality, outcomes, and financial performance of the U.S. healthcare system. "MedAssurant maintains a rich clinical data warehouse, the Medical Outcomes Research for Effectiveness & Economics (MORE2) Registry, which is unique within the healthcare community," said Cary Sennett, MD, PhD, MedAssurant's Chief Medical Officer. "This Registry and the data collection, aggregation, and analysis infrastructure which support it, enable advanced insights that are empowering meaningful improvements in the care for patients. Our partnership with the School of Population Health at Thomas Jefferson University helps us to further advance and expand these efforts. It is a pleasure and privilege to be working together in the advancement of healthcare effectiveness research."

The relationship will focus on applications of Comparative Effectiveness Research (CER), Health Economic Outcomes Research (HEOR), safety and surveillance initiatives, and pharmacoeconomics research. Thomas Jefferson University will also provide Institutional Review Board (IRB) services for research undertaken through the partnership in supporting needs of clinical trials and other similar initiatives.


About Thomas Jefferson University

Thomas Jefferson University, the largest freestanding academic medical center in Philadelphia, is composed of Jefferson Medical College, Jefferson College of Graduate Studies, Jefferson School of Population Health, Jefferson School of Health Professions, Jefferson School of Pharmacy, and Jefferson School of Nursing. Jefferson is regarded nationally as one of the best universities offering a range of comprehensive programs for the education of health professions. The university enrolls more than 2,900 future physicians, scientists and health care professionals. Thomas Jefferson University partners with Thomas Jefferson University Hospital, its education and clinical care affiliate.


About MedAssurant, Inc.

MedAssurant, Inc. is a leading healthcare solutions provider focused on the importance of healthcare data and its ability to drive dramatic, objective improvements in clinical and quality outcomes, care management, and financial performance throughout the healthcare community. Proprietary healthcare datasets, aggregation, and analysis capabilities, combined with a national infrastructure of leading-edge technology, clinical prowess, and deep human resources empowers MedAssurant's advanced generation of healthcare assessment and improvement through highly informed solutions. In partnership with many members of the healthcare community, MedAssurant provides local, regional, and nationwide health insurance plans, hospitals, pharmaceutical companies, regulatory bodies, government organizations, physician organizations, and their many coveted patients with powerful turnkey solutions to address matters of clinical outcomes analysis, quality of care, cost improvement, risk adjustment, disease management, utilization, and healthcare data verification. Driven by a mission to improve today's healthcare landscape, the employees of MedAssurant proudly apply care, ingenuity, and dedication to delivering a new approach to healthcare - one driven by data and insight - one resulting in meaningful action.

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.